Basic and clinical study of stem cell treatment for diabetes mellitus in China
2018
Pancreatic islet beta cell dysfunction and insulin
resistance are the main mechanisms underlying the development of diabetes
mellitus. The current anti-diabetic treatments only alleviate symptoms
and may delay the progression of the disease, but cannot cure the
disease. Stem cells improve the function of islet beta cells by promoting in situ regeneration and repair mechanisms that improve
autophagy of islet beta cells and modulate macrophage function. They
also ameliorate the insulin resistance in peripheral tissues by activating
the IRS-1-AKT-GLUT4 signaling pathway in skeletal muscle, fat, and
liver. Stem cell therapy has provided a new direction for the precise
treatment of diabetes. Researchers in China have carried out a series
of experiments on different sources of stem cell therapy for diabetes
mellitus using different infusion methods, and they have achieved
good clinical effects without serious adverse reactions. These results
have provided a basis for the clinical application of stem cells in
the treatment of diabetes mellitus.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI